DexCom is a corporate venture capital investor based in San Diego backing healthcare technology aligned with Dexcom’s strategy, including biosensing, data-driven healthcare, chronic disease innovation and adjacent health conditions beyond diabetes. It invests from early-stage through later-stage venture rounds, with activity in the United States and Europe, and is relevant for startups in HealthTech, medical devices, wellness, life sciences, wearables, IoT, data and related cybersecurity-enabled health infrastructure.